Lassen Therapeutics
Latest round
- Series B
Last raised
- Dec 2023
Total raised
- $116M
Investors
- 7
About Lassen Therapeutics
Founded in 2019 and based in California, US, Lassen Therapeutics, LLC operates as a health technology company that develops and manufactures novel medicines for rare diseases. As of 2023, the firm is headed by its CEO Maria Fardis. The company develops antibodies as potential treatments for fibrosis, rare diseases, oncology, and thyroid eye disease. The firm science includes IL-11 which serves as the treatment for fibro-inflammatory diseases such as thyroid eye disease (TED) and idiopathic pulmonary fibrosis (IPF).
Who invested in Lassen Therapeutics
7 investors across 2 rounds
See all investors in Lassen Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Lassen Therapeutics
Who invested in Lassen Therapeutics?
Lassen Therapeutics has 7 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Lassen Therapeutics raised?
Lassen Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Lassen Therapeutics last raise money?
Lassen Therapeutics's most recent round on record is a Series B, in Dec 2023.
What does Lassen Therapeutics do?
Founded in 2019 and based in California, US, Lassen Therapeutics, LLC operates as a health technology company that develops and manufactures novel medicines for rare diseases.
Where is Lassen Therapeutics headquartered?
Lassen Therapeutics is headquartered in San Diego, US.
Which VCs invest in companies like Lassen Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Lassen Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Lassen Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.